| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/21/2011 | US20110178009 Pheromones and the Luteinizing Hormone for Inducing Proliferation of Neural Stem Cells and Neurogenesis |
| 07/21/2011 | US20110177999 Therapeutic Combinations Useful in Treating CFTR Related Diseases |
| 07/21/2011 | US20110177997 Cross-Beta Silk Genes |
| 07/21/2011 | US20110177996 Regulatory proteins in lung repair and treatment of lung disease |
| 07/21/2011 | US20110177600 Protein production using eukaryotic cell lines |
| 07/21/2011 | US20110177599 Delivery of nucleic acids across membranes |
| 07/21/2011 | US20110177598 Method for cellular tissue multiplication from jatropha curcas |
| 07/21/2011 | US20110177597 Cellular differentiation process and its use for blood vessel build-up |
| 07/21/2011 | US20110177596 Device for enhancing immunostimulatory capabilities of T-cells |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177594 Stem cells culture systems |
| 07/21/2011 | US20110177593 Low rigidity gels for msc growth modulation |
| 07/21/2011 | US20110177592 Magnetic apparatus for blood separation |
| 07/21/2011 | US20110177591 Method and device for producing dermis |
| 07/21/2011 | US20110177590 Bioprinted Nanoparticles and Methods of Use |
| 07/21/2011 | US20110177589 Novel human polyomavirus |
| 07/21/2011 | US20110177557 Fusion Protein and Use Thereof |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |
| 07/21/2011 | US20110177555 Chinese hamster ovary cell lines |
| 07/21/2011 | US20110177554 Secreted frizzled related protein, sfrp, fragments and methods of use thereof |
| 07/21/2011 | US20110177540 Mutant luciferase |
| 07/21/2011 | US20110177524 Recombinant Fibrinogen |
| 07/21/2011 | US20110177522 Methods for Producing Olfactory GPCRs |
| 07/21/2011 | US20110177497 Thermus Thermophilus Nucleic Acid Polymerases |
| 07/21/2011 | US20110177488 Biological material and methods and solutions for preservation thereof |
| 07/21/2011 | US20110177228 Plant nucelotide sequences and corresponding polypeptides |
| 07/21/2011 | US20110177185 Pharmaceutically compatible method for purifying intact bacterial minicells |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177155 Methods of delivery of agents to leukocytes and endothelial cells |
| 07/21/2011 | US20110177132 Compositions and Methods for Generating Musculoskeletal Tissue |
| 07/21/2011 | US20110177118 Non-Simian Cells for Growth of Porcine Reproductive and Respiratory Syndrome (PRRS) Virus |
| 07/21/2011 | US20110177117 Chimeric respiratory syncytial virus polypeptide antigens |
| 07/21/2011 | US20110177104 Method for selective depletion of cd137 positive cells using anti-cd137 antibody-toxin complex |
| 07/21/2011 | US20110177102 Targeted double stranded rna mediated cell killing |
| 07/21/2011 | US20110177098 Tm4sf4 and modulators thereof and methods for their use |
| 07/21/2011 | US20110177096 Use of gpr151 modulators for the treatment of pain |
| 07/21/2011 | US20110177095 Anti-her2 antibodies and their uses |
| 07/21/2011 | US20110177089 Apoptosis inducer |
| 07/21/2011 | US20110177088 Method for Treating and Diagnosing Hematologic Malignancies |
| 07/21/2011 | US20110177087 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177076 Humanized anti-amyloid beta antibodies |
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177073 Recombinant production of mixtures of antibodies |
| 07/21/2011 | US20110177070 TGF-Beta Antagonist Multi-Target Binding Proteins |
| 07/21/2011 | US20110177069 Novel inducer of chondrocyte proliferation and differentiation |
| 07/21/2011 | US20110177062 Methods for treating breast cancer |
| 07/21/2011 | US20110177058 Methods and compositions for modulating hgf/met |
| 07/21/2011 | US20110177054 Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| 07/21/2011 | US20110177045 Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders |
| 07/21/2011 | US20110177043 Method of improving differentiation of chondrogenic progenitor cells |
| 07/21/2011 | US20110177042 Method for Dedifferentiating Melanocytes |
| 07/21/2011 | US20110177040 Cytokine Induction Of Selectin Ligands On Cells |
| 07/21/2011 | US20110177038 Inhibition of Tumor Growth via Peroxiredoxin 3 |
| 07/21/2011 | US20110177036 Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments |
| 07/21/2011 | US20110177033 Ras responsive element binding protein 1 (rreb1) as a therapeutic target for thalassemias and sickle cell anemia |
| 07/21/2011 | US20110177032 Use on oncolytic herpes viruses for killing cancer stem cells |
| 07/21/2011 | US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases |
| 07/21/2011 | US20110177025 Wound healing |
| 07/21/2011 | US20110177023 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177001 Screening assay employing dex and gdf8 |
| 07/21/2011 | US20110176998 Imaging and therapy of virus-associated tumors |
| 07/21/2011 | DE102010018109A1 New sulfate transferase comprising specified amino acid sequence or its partial sequence or conservative variations, useful to produce sulfated compounds including liponucleoside derivatives, nucleoside derivatives and aromatic compounds |
| 07/21/2011 | CA2787050A1 Bioengineered tissue constructs and methods for producing and using thereof |
| 07/21/2011 | CA2787027A1 Detection of gastrointestinal disorders |
| 07/21/2011 | CA2787016A1 Therapeutic apyrase constructs, apyrase agents, and production methods |
| 07/21/2011 | CA2787007A1 Materials and methods for producing cell-surface directed and associated non-naturally occurring bioinorganic membranes and uses thereof |
| 07/21/2011 | CA2786660A1 Liver targeting molecules |
| 07/21/2011 | CA2786201A1 Novel mannanase variants |
| 07/21/2011 | CA2782757A1 Stem cell immune modulation methods of use and apparatus |
| 07/20/2011 | EP2345742A1 RNA sequence-specific mediators of RNA interference |
| 07/20/2011 | EP2345730A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
| 07/20/2011 | EP2345729A2 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar |
| 07/20/2011 | EP2345722A1 Mutations in the parkin gene, compositions, methods and uses |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2345715A2 Schwann cells originating in myeloid interstitial cells |
| 07/20/2011 | EP2345714A1 Cell storage method and cell transport method |
| 07/20/2011 | EP2345713A1 A concentrated culture solution and application method thereof |
| 07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345670A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/20/2011 | EP2345665A2 Flavivirus NS1 subunit vaccine |
| 07/20/2011 | EP2345423A1 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 07/20/2011 | EP2344648A2 Recombinant vectors |
| 07/20/2011 | EP2344633A2 Method of improving differentiation of chondrogenic progenitor cells |
| 07/20/2011 | EP2344632A2 Method for inducing pluripotency in cells |
| 07/20/2011 | EP2344631A1 Method and device for activating stem cells |
| 07/20/2011 | EP2344630A2 Cell growth |
| 07/20/2011 | EP2344625A2 Methods and compositions for high-resolution micropatterning for cell culture |
| 07/20/2011 | EP2344622A1 Apparatus for culturing anchorage dependent cells |
| 07/20/2011 | EP2344181A1 Use of ctgf as a cardioprotectant |
| 07/20/2011 | EP1999250B1 Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method |
| 07/20/2011 | EP1994156B1 Chimeric tymovirus-like particles |
| 07/20/2011 | EP1969119B1 Multipotent neural stem cells |
| 07/20/2011 | EP1833961B1 Methods for culturing mammalian taste cells |
| 07/20/2011 | EP1692168B1 Single-chain insulin |